TABLE 1.
Adverse Events Irrespective of Causality Occurring in ≥ 10% Patients Treated With MP0274 in the Overall Dose Escalation Cohort
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.